Trials / Completed
CompletedNCT00858988
Trial of Rifaximin in the Treatment of Tropical Enteropathy
A Randomized, Double-blind, Placebo-controlled Trial of Rifaximin, a Non-absorbable Antibiotic, in the Treatment of Tropical Enteropathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 147 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 3 Years – 5 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether rifaximin is effective in the treatment of tropical enteropathy in a population of African children at high risk for this disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rifaximin | 100mg of rifaxin for 7 consecutive days, twice daily |
| DRUG | Placebo | twice daily for 7 consecutive days |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2009-03-10
- Last updated
- 2019-11-12
- Results posted
- 2019-11-12
Locations
1 site across 1 country: Malawi
Source: ClinicalTrials.gov record NCT00858988. Inclusion in this directory is not an endorsement.